Humira adalimumab regulatory update

EMA's CHMP issued a positive opinion recommending approval of Humira adalimumab from Abbott to treat moderate to severe active ulcerative colitis in adults who failed conventional therapies. Abbott expects to receive a final decision in the next few weeks. ...